NSE ScannerHospitals & Diagnostics · Hospital/Nursing Management · NSE: MAITREYA · data 2026-10-31
Maitreya Medicare Limited
In plain words
Price: 57.3% below its 52-week high of ₹292.95.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹45 cr |
| Net profit (last 12 months) | ₹-3 cr |
| Sales growth, 3 years (yearly) | — |
| Profit growth, 3 years (yearly) | — |
At a glance
ROE -8.1%, ROCE -3.3%, operating margin -3.7%: how much profit it earns on the money it uses.
Debt/equity 1.13, Profit growth — and sales growth — a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
None flagged by these rules.
- Low return on equity (-8.1%).
- Thin operating margin (-3.7%).
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
5/100 · Weak over the last ~60 sessions
- Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is Maitreya Medicare Limited debt-free?
Its latest reported debt-to-equity ratio is 1.13, meaning borrowings are larger than shareholders' equity.
What is the 52-week high and low of Maitreya Medicare Limited?
The 52-week high is ₹292.95 and the 52-week low is ₹103.1.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Maitreya Medicare Limited | ₹125 | ₹85 cr | — | 3.6 | -8.1% | -3.3% | 1.13 | -46.8% |
| GPT Healthcare Limited | ₹132.68 | ₹1,089 cr | 23 | — | 16.3% | 16.2% | 0.34 | -11.6% |
| KRM Ayurveda Ltd. | ₹225.45 | ₹479 cr | — | — | — | — | — | +31.0% |
| Sangani Hospital Ltd. | ₹62.3 | ₹86 cr | 17.2 | 2.1 | 7.8% | 15.9% | 0.04 | -1.1% |
| Aatmaj Healthcare Limited | ₹23.8 | ₹54 cr | 94.7 | 1.1 | 1.4% | 2.6% | 0.41 | +16.1% |
| ABH Healthcare Limited | ₹42 | ₹48 cr | — | — | — | — | — | -57.6% |
Compare MAITREYA with GPTHEALTH in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open MAITREYA in NSE Scanner →